Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial

Bridget C. Howard*, Hayden McRobbie, Dennis Petrie, Daniel Barker, Colin Mendelsohn, Jack Anderson, Ron Borland, Felix Naughton, Piotr Tutka, Nick Zwar, Veronica C. Boland, Alexandra Aiken, Anthony Shakeshaft, Coral Gartner, Robyn L. Richmond, Wayne Hall, Richard P. Mattick, Michael Farrell, Ryan J. Courtney

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)
27 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences